Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -21.74%2.77B | -0.55%14.19B | 3.24%3.54B | 1.92%14.27B | 15.61%3.56B | -1.22%3.76B | 2.79%3.51B | -7.05%3.43B | -9.54%14B | -14.89%3.08B |
| Cost of revenue | -35.71%1.39B | 6.04%8.02B | 25.17%2.17B | -2.01%7.57B | 12.78%1.93B | 5.29%2.11B | -8.59%1.8B | -15.21%1.73B | -9.42%7.72B | -13.32%1.71B |
| Gross profit | 0.27%1.38B | -7.99%6.17B | -19.11%1.38B | 6.77%6.7B | 19.15%1.63B | -8.41%1.66B | 18.23%1.71B | 3.04%1.7B | -9.68%6.28B | -16.78%1.37B |
| Operating expense | -17.83%1.47B | 9.96%7.19B | 25.16%1.79B | 16.12%6.54B | 39.68%1.72B | 39.61%1.95B | -10.01%1.44B | 1.82%1.43B | -1.40%5.63B | 6.56%1.23B |
| Operating profit | 78.08%-90.61M | -736.34%-1.03B | -252.50%-413.35M | -75.00%161.19M | -167.85%-91.92M | -171.01%-292.94M | 284.01%275M | 10.04%271.05M | -47.91%644.85M | -72.22%135.47M |
| Net non-operating interest income (expenses) | -1,162.98%-61.28M | -579.88%-107.48M | -175.61%-4.85M | -40.90%22.4M | -42.47%4.94M | 7.89%9.71M | -90.01%1.34M | -7.66%6.42M | 877.42%37.9M | -52.91%8.59M |
| Non-operating interest income | -42.64%12.18M | 1.51%88.43M | 13.73%21.24M | 1.84%87.11M | 17.98%23.78M | 35.42%27.26M | -31.89%17.4M | -5.22%18.68M | 41.73%85.54M | -34.01%20.15M |
| Non-operating interest expense | 224.67%68.46M | 293.61%175.88M | 190.79%21.09M | 61.86%44.68M | 110.87%13.83M | 104.80%12.55M | 54.12%11.06M | -6.40%7.25M | -38.92%27.61M | -10.10%6.56M |
| Total other finance cost | 0.00%5.01M | 0.00%20.03M | 0.00%5.01M | 0.00%20.03M | 0.00%5.01M | 0.00%5.01M | 0.00%5.01M | 0.00%5.01M | 0.00%20.03M | 0.00%5.01M |
| Net investment income | -208.51%-3.38M | -373.36%-21.65M | -31.94%3.12M | 12.92%7.92M | 1,864.14%3.89M | 46.48%-2.68M | -47.30%2.13M | -41.12%4.58M | -34.44%7.01M | 198K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 25.43%1.1B | -75.74%50.62M | 2,507.05%878.7M | 58.43%-20.77M | -792.26%-58.47M | 16,431.80%749.22M | 43,931.43%208.71M | 94.54%-36.51M | 93.00%-49.96M |
| Income from associates and other participating interests | -68.53%-27.53M | 33.95%-40.09M | 38.52%-16.34M | -115.58%-60.69M | 27.77%-13.02M | -4.54%-9.99M | -389.68%-11.11M | -502.68%-26.57M | 22.92%-28.15M | -58.44%-18.03M |
| Special income (charges) | -1,081.54%-13.06M | -209.35%-573.94M | -100.51%-1.11M | 335.72%524.86M | -185.20%-97.99M | 6,478.16%425.42M | -700.68%-18.44M | 2,286.88%215.87M | 135.28%120.46M | 135.17%115.02M |
| Less:Other special charges | 1,081.54%13.06M | 106.87%36.07M | 100.51%1.11M | -242.28%-524.86M | 168.44%97.99M | -6,478.16%-425.42M | 700.68%18.44M | -1,468.36%-215.87M | -2,225.83%-153.34M | -268.07%-143.18M |
| Less:Write off | ---- | --537.87M | ---- | --0 | --0 | --0 | --0 | --0 | -90.55%32.88M | -88.36%28.16M |
| Other non-operating income (expenses) | -138.31%-7.11M | 137.49%146.73M | 879.99%18.56M | 569.30%61.78M | 213.28%35.83M | 104.56%5.65M | 432.33%22.68M | -110.56%-2.38M | -218.96%-13.17M | -558.93%-31.63M |
| Income before tax | 44.14%-202.96M | -132.57%-519.94M | -153.62%-363.35M | 117.94%1.6B | -212.14%-179.04M | -81.36%76.71M | 901.10%1.02B | 134.75%677.67M | 251.26%732.4M | 130.22%159.65M |
| Income tax | 45.37%-40.63M | -98.35%10.19M | -125.89%-74.37M | 26.21%617.04M | -85.55%17.8M | -117.28%-32.96M | 563.76%344.91M | 133.56%287.29M | 1,391.26%488.89M | 136.36%123.22M |
| Net income | 43.82%-162.34M | -154.14%-530.12M | -174.02%-288.98M | 302.09%979.11M | -640.33%-196.84M | -50.33%109.67M | 476.78%675.9M | 135.63%390.39M | 38.58%243.5M | 119.23%36.43M |
| Net income continuous operations | 43.82%-162.34M | -154.14%-530.12M | -174.02%-288.98M | 302.09%979.12M | -640.31%-196.84M | -50.33%109.67M | 476.78%675.9M | 135.63%390.39M | 38.58%243.51M | 119.23%36.43M |
| Noncontrolling interests | 23.04%-2.57M | 100.93%272K | -24.50%-3.33M | -156.08%-29.12M | -1,019.78%-22.08M | 36.51%-2.39M | 26.61%-1.97M | 9.22%-2.68M | 91.56%-11.37M | 98.68%-1.97M |
| Net income attributable to the company | 44.07%-159.77M | -152.61%-530.4M | -172.67%-285.64M | 295.58%1.01B | -555.07%-174.76M | -50.10%112.06M | 483.63%677.88M | 133.10%393.06M | -17.90%254.88M | 195.88%38.4M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 44.07%-159.77M | -152.61%-530.4M | -172.67%-285.64M | 295.58%1.01B | -555.07%-174.76M | -50.10%112.06M | 483.63%677.88M | 133.10%393.06M | -17.90%254.88M | 195.88%38.4M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 40.04%-16.7 | -158.96%-53.74 | -178.81%-27.85 | 297.69%91.15 | -539.60%-15.21 | -50.12%10.07 | 483.57%60.95 | 133.11%35.34 | -17.88%22.92 | 196.11%3.46 |
| Diluted earnings per share | 40.04%-16.7 | -160.18%-53.74 | -180.91%-27.85 | 301.35%89.3 | -560.91%-15.21 | -50.12%10.07 | 471.74%59.07 | 127.04%34.42 | -13.59%22.25 | 191.67%3.3 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |